Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Parkinsonism Relat Disord. 2011 Oct 21;18(3):230–233. doi: 10.1016/j.parkreldis.2011.10.006

Table 1.

Demographic and Disease Activity Measures of the NET-PD FS Trial Participants

FS-1
FS-Too
Total
BASELINE N 200 213 413
Age (years) 62.3 (10.4) 61.0 (10.4) 61.7 (10.4)
Gender (%) 126 (63.0%) 139 (65.3%) 265 (64.2%)
Non-Hispanic Caucasian (%) 185 (92.5%) 191 (90.0%) 376 (91.0%)
Duration (years) 0.7 (0.8) 0.7 (0.9) 0.7 (0.8)
Education (years) 15.1 (3.2) 15.3 (3.2) 15.2 (3.2)
UPDRS Total 23.7 (9.5) 22.3 (8.9) 23.0 (9.2)
UPDRS-I 1.3 (1.5) 1.0 (1.3) 1.1 (1.4)
UPDRS-I Participant 1.9 (1.7) 1.4 (1.5) 1.7 (1.6)
UPDRS-II 6.2 (3.4) 5.8 (3.1) 6.0 (3.3)
UPDRS-II Participant 6.9 (3.8) 6.4 (3.6) 6.6 (3.7)
UPDRS-III 16.2 (7.0) 15.6 (6.5) 15.9 (6.7)

ENDPOINT UPDRS Total 27.8 (12.5) 25.9 (11.1) 26.8 (11.8)
UPDRS-I 1.5 (1.7) 1.2 (1.3) 1.4 (1.5)
UPDRS-I Participant 1.9 (1.7) 1.4 (1.7) 1.7 (1.7)
UPDRS-II 8.0 (4.4) 7.0 (3.9) 7.5 (4.1)
UPDRS-II Participant 8.2 (4.7) 7.5 (4.4) 7.8 (4.6)
UPDRS-III 18.3 (8.7) 17.7 (7.9) 18.0 (8.3)